A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin(Hospital of the University of Pennsylvania), S Badve(Einstein Medical Center Philadelphia), Lorie L. Hughes(Memorial Sloan Kettering Cancer Center), Nancy E. Davidson(WinnMed), Carl Yoshizawa(Einstein Medical Center Philadelphia), Edith A. Perez(Unknown), Frederick L. Baehner(University of California, San Francisco), Robert P. Gray(Einstein Medical Center Philadelphia), Diana B. Cherbavaz(Einstein Medical Center Philadelphia), Joseph A. Sparano(Tisch Cancer Institute), David L. Page(Duke University), J. N. Ingle(Mayo Clinic), G. W. Sledge(Stanford Medicine), W. C. Wood(Emory University), Steven M. Butler(Einstein Medical Center Philadelphia), S. Shak(Einstein Medical Center Philadelphia)
Cited by 523
Related Papers
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
|New England Journal of Medicine|1985|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k